Houssein Abdul Sater

发表

Validity of 1% Hormonal Receptor Positivity Cutoff by the ASCO/College of American Pathologists Guidelines at the Georgia Cancer Center

Hiral S. Patel, Shou-Ching Tang, F. Kreidieh, 2022, JCO precision oncology.

A Randomized Phase II Trial of mFOLFOX6 + Bevacizumab Alone or with AdCEA Vaccine + Avelumab Immunotherapy for Untreated Metastatic Colorectal Cancer.

S. Steinberg, J. Marshall, J. Schlom, 2022, The oncologist.

Combining a β3 adrenergic receptor agonist with alpha‐lipoic acid reduces inflammation in male mice with diet‐induced obesity

O. Gavrilova, A. Cypess, Naili Liu, 2021, Obesity.

Therapy of Established Tumors with Rationally Designed Multiple Agents Targeting Diverse Immune–Tumor Interactions: Engage, Expand, Enable

J. Schlom, Benjamin Wolfson, R. Fujii, 2020, Cancer Immunology Research.

Phase I study of a multitargeted recombinant Ad5 PSA/MUC-1/brachyury-based immunotherapy vaccine in patients with metastatic castration-resistant prostate cancer (mCRPC)

J. Schlom, R. Madan, Marijo Bilusic, 2021, Journal for ImmunoTherapy of Cancer.

Nascent prostate cancer heterogeneity drives evolution and resistance to intense hormonal therapy

P. Choyke, M. Merino, S. Harmon, 2020, medRxiv.

If we build it they will come: targeting the immune response to breast cancer

D. Cescon, S. Adams, H. McArthur, 2019, npj Breast Cancer.

Neoadjuvant PROSTVAC prior to radical prostatectomy enhances T-cell infiltration into the tumor immune microenvironment in men with prostate cancer

S. Steinberg, P. Choyke, S. Harmon, 2020, Journal for ImmunoTherapy of Cancer.

Phase II evaluation of the triple combination of PDS0101, M9241, and bintrafusp alfa in patients with HPV 16 positive malignancies.

J. Schlom, R. Madan, Marijo Bilusic, 2021 .

Chimeric antigen receptor engineered NK cellular immunotherapy overcomes the selection of T-cell escape variant cancer cells

J. Schlom, J. Friedman, P. Soon-Shiong, 2021, Journal for ImmunoTherapy of Cancer.

If we build it they will come: targeting the immune response to breast cancer

D. Cescon, S. Adams, H. McArthur, 2019, npj Breast Cancer.

Lung cancer trends: smoking, obesity, and sex assessed in the Staten Island University’s lung cancer patients

V. Bhatt, Shilpi Gupta, Houssein Abdul Sater, 2014, International journal of general medicine.

Dual PD-L1 and TGF-b blockade in patients with recurrent respiratory papillomatosis

J. Schlom, J. Friedman, J. Gulley, 2021, Journal for ImmunoTherapy of Cancer.

The co-chaperone UNC45A is essential for the expression of mitotic kinase NEK7 and tumorigenesis

Huidong Shi, J. Roig, J. Cowell, 2019, The Journal of Biological Chemistry.

A phase I/II study of bintrafusp alfa and NHS-IL12 in combination with docetaxel in adults with metastatic castration sensitive (mCSPC) and castration-resistant prostate cancer (mCRPC).

J. Schlom, W. Figg, R. Madan, 2021 .

Efficacy, safety, and biomarker analyses of bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, in patients with advanced non-small cell lung cancer

J. Marté, E. Lamping, Houssein Abdul Sater, 2024, Journal for ImmunoTherapy of Cancer.